Search Results - "Canziani, M.E."

Clinical Implications of Initial Renal Function After Deceased Donor Transplant by Guimarães-Souza, N, Dalboni, M.A, Canziani, M.E, Tedesco-Silva, H, Batista, M.C, Sesso, R, Câmara, N.O, Medina-Pestana, J.O, Pacheco-Silva, A, Cendoroglo, M

“…Abstract The aim of this study was to investigate whether slow graft function (SGF) after transplantation of deceased-donor kidneys affected the prevalence of…”
Get full text

Dialysis Adequacy After Deceased Donor Transplantation by Guimaraes-Souza, N.K, Dalboni, M.A, Batista, M.C, Canziani, M.E, Câmara, N.O.S, Pacheco-Silva, A, Medina-Pestana, J.O, Cendoroglo, M

“…Abstract Delayed graft function (DGF) is defined as the necessity for dialysis during the first week after transplantation. This study sought to describe…”
Get full text

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function by Heerspink, Hiddo J L, Cherney, David, Postmus, Douwe, Stefánsson, Bergur V, Chertow, Glenn M, Dwyer, Jamie P, Greene, Tom, Kosiborod, Mikhail, Langkilde, Anna Maria, McMurray, John J V, Correa-Rotter, Ricardo, Rossing, Peter, Sjöström, C David, Toto, Robert D, Wheeler, David C

“…This pre-specified analysis of DAPA-CKD assessed the impact of sodium-glucose cotransporter 2 inhibition on abrupt declines in kidney function in high-risk…”
Get more information

SAT-206 EFFECT OF FRUTOOLIGOSACCHARIDE ON ENDOTHELIAL FUNCTION IN CKD PATIENTS: A RANDOMIZED CONTROLLED TRIAL by ARMANI, R., Ishikawa, C., Hong, V., Bortolotto, L.A., Cassiolatto, J.L., Klassen, A., Cuppari, L., Canziani, M.E.

Get full text

Hemodialysis versus continuous ambulatory peritoneal dialysis: effects on the heart by Canziani, M E, Cendoroglo Neto, M, Saragoça, M A, Cassiolato, J L, Ramos, O L, Ajzen, H, Draibe, S A

“…In this study we compared the influence of 2 different modalities of treatment, CAPD and hemodialysis, on the prevalence and severity of left ventricular…”
Get more information

Osteoporosis in hemodialysis patients revisited by bone histomorphometry: A new insight into an old problem by Barreto, F.C., Barreto, D.V., Moyses, R.M.A., Neves, C.L., Jorgetti, V., Draibe, S.A., Canziani, M.E., Carvalho, A.B.

“…Osteoporosis in hemodialysis patients is associated with high morbidity and mortality and, although extensively studied by noninvasive methods, has never been…”
Get full text

Serum-soluble Fas and serum levels of erythropoietin in chronic kidney disease by Góes, M A, Dalboni, M A, Manfredi, S R, Cendoroglo, M S, Batista, M C, Canziani, M E, Balakrishnan, V S, Pereira, B J G, Draibe, S A, Cendoroglo, M

“…Soluble Fas levels (sFas) are increased in the serum of uremic patients and are associated with the presence of anemia and recombinant human EPO (rHuEPO)…”
Get more information

Reversal of left ventricular hypertrophy with isradipine induces diminution of cardiac arrhythmias by Saragoça, M A, Cassiolatto, J L, Vanetta, A M, Canziani, M E, Abreu, P, Ventura, R T, Ramos, O L

“…The left ventricular hypertrophy (LVH) of hypertension is often associated with ventricular arrhythmias, which may increase the risk of cardiovascular…”
Get more information

Dipyridamole-thallium tests are predictive of severe cardiac arrhythmias in patients with left ventricular hypertrophy by Saragoça, M A, Canziani, M E, Gil, M A, Castiglioni, M L, Cassiolato, J L, Barbieri, A, Lima, V C, Draibe, S A, Martinez, E E

“…In a population of patients with chronic renal failure (CRF) and a high prevalence of left ventricular hypertrophy (LVH) undergoing chronic hemodialysis, we…”
Get more information